Literature DB >> 21882203

Swallowing function after transoral laser microsurgery (TLM) ± adjuvant therapy for advanced-stage oropharyngeal cancer.

Jason T Rich1, Jingxia Liu, Bruce H Haughey.   

Abstract

OBJECTIVES/HYPOTHESIS: To perform a longitudinal description of swallowing function following transoral laser microsurgery (TLM) ± adjuvant therapy for advanced-stage oropharyngeal cancer (OPC) and identify prognostic factors associated with swallowing performance. STUDY
DESIGN: Retrospective analysis and longitudinal descriptive study of swallowing outcomes.
METHODS: Patients treated with TLM for AJCC stage III-IV OPC at Washington University from 1996 to 2008 were included. A search of medical records and direct patient contact were performed to obtain swallowing function at multiple time points. Persistently poor swallowing at 2 year after surgery was the primary outcome measure. Two year swallowing outcomes stratified by tumor site and T stage are presented.
RESULTS: One hundred eighteen patients met criteria for the study (median follow-up 53.9 months). There were 44 T1's, 41 T2's, 23 T3's and 10 T4's. Forty seven percent received radiotherapy and 41% received chemoradiotherapy. Ninety-eight percent underwent neck dissection. Patients tolerated TLM well with 82% enjoying good swallowing at 1 month after surgery. During adjuvant therapy, at 3 months, good swallowing dropped to 55%. At 1 and 2 years after TLM, 89% and 88% of patients had good swallowing function, respectively. At 2 years, 9 patients had persistently poor swallowing function. 93% of patients with T1 through T3 enjoyed good swallowing at 2 years. T4 base of tongue disease was associated with persistently poor swallowing function in multivariate analyses (P = 0.0023), with 40% having good swallowing at 2 years. Preexisting comorbidities and conversion to an open procedure were associated with delayed return of swallowing function, but not with persistently poor swallowing. Seven patients developed late-onset swallowing dysfunction.
CONCLUSIONS: Treatment of advanced stage OPC with TLM ± adjuvant therapy results in excellent swallowing outcomes for patients with either T1 to T3 tonsil or T1 to T3 base of tongue resections. A detailed, longitudinal swallowing profile is presented to assist in preoperative counseling.
Copyright © 2011 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21882203      PMCID: PMC4201117          DOI: 10.1002/lary.21406

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  27 in total

1.  Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.

Authors:  Jay S Cooper; Thomas F Pajak; Arlene A Forastiere; John Jacobs; Bruce H Campbell; Scott B Saxman; Julie A Kish; Harold E Kim; Anthony J Cmelak; Marvin Rotman; Mitchell Machtay; John F Ensley; K S Clifford Chao; Christopher J Schultz; Nancy Lee; Karen K Fu
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

2.  Transoral carbon dioxide laser ablation for cancer, tumors, and other diseases.

Authors:  W R Panje; N Scher; M Karnell
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1989-06

3.  Transoral resection of tonsillar squamous cell carcinoma.

Authors:  Eric J Moore; Doug K Henstrom; Kerry D Olsen; Jan L Kasperbauer; Michaela E McGree
Journal:  Laryngoscope       Date:  2009-03       Impact factor: 3.325

4.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Authors:  Carole Fakhry; William H Westra; Sigui Li; Anthony Cmelak; John A Ridge; Harlan Pinto; Arlene Forastiere; Maura L Gillison
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

5.  Swallowing-related quality of life after head and neck cancer treatment.

Authors:  M Boyd Gillespie; Martin B Brodsky; Terry A Day; Fu-Shing Lee; Bonnie Martin-Harris
Journal:  Laryngoscope       Date:  2004-08       Impact factor: 3.325

Review 6.  Dysphagia following chemoradiation for locally advanced head and neck cancer.

Authors:  N P Nguyen; C C Moltz; C Frank; P Vos; H J Smith; U Karlsson; S Dutta; F A Midyett; J Barloon; S Sallah
Journal:  Ann Oncol       Date:  2004-03       Impact factor: 32.976

7.  Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14).

Authors:  Adam S Garden; Jonathan Harris; Andy Trotti; Christopher U Jones; Luis Carrascosa; Jonathan D Cheng; Sharon S Spencer; Arlene Forastiere; Randal S Weber; K Kian Ang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-08-01       Impact factor: 7.038

8.  Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis.

Authors:  Mitchell Machtay; Jennifer Moughan; Andrew Trotti; Adam S Garden; Randal S Weber; Jay S Cooper; Arlene Forastiere; K Kian Ang
Journal:  J Clin Oncol       Date:  2008-06-16       Impact factor: 44.544

9.  Transoral laser microsurgery for advanced laryngeal cancer.

Authors:  Michael L Hinni; John R Salassa; David G Grant; Bruce W Pearson; Richard E Hayden; Alexios Martin; Hans Christiansen; Bruce H Haughey; Brian Nussenbaum; Wolfgang Steiner
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2007-12

10.  Prognostic importance of comorbidity in a hospital-based cancer registry.

Authors:  Jay F Piccirillo; Ryan M Tierney; Irene Costas; Lori Grove; Edward L Spitznagel
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

View more
  22 in total

1.  Swallowing, speech and quality of life in patients undergoing resection of soft palate.

Authors:  Lívia Fernandes Barata; Genival Barbosa de Carvalho; Elisabete Carrara-de Angelis; José Carlos Marques de Faria; Luiz Paulo Kowalski
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-04-22       Impact factor: 2.503

2.  Severe prolonged dysphagia following transoral resection of bilateral synchronous tonsillar carcinoma.

Authors:  Alpen B Patel; Michael L Hinni; Taylor R Pollei; Richard E Hayden; Eric J Moore
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-08       Impact factor: 2.503

Review 3.  Surgical Options for Locally Advanced Oropharyngeal Cancer.

Authors:  Hannan A Qureshi; Marianne Abouyared; Brittany Barber; Jeffrey J Houlton
Journal:  Curr Treat Options Oncol       Date:  2019-04-01

Review 4.  A novel distending laryngoscope: implications in transoral surgery.

Authors:  Michael L Hinni; Alpen B Patel; Thomas H Nagel; Brittany E Howard
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-31       Impact factor: 2.503

Review 5.  The role for surgical management of HPV-related oropharyngeal carcinoma.

Authors:  Eric M Genden
Journal:  Head Neck Pathol       Date:  2012-07-03

6.  Transoral robotic surgery for the base of tongue squamous cell carcinoma: a preliminary comparison between da Vinci Xi and Si.

Authors:  Marco Alessandrini; Isabella Pavone; Alessandro Micarelli; Claudio Caporale
Journal:  J Robot Surg       Date:  2017-09-13

Review 7.  Will the mininvasive approach challenge the old paradigms in oral cancer surgery?

Authors:  G Tirelli; S Zacchigna; F Boscolo Nata; E Quatela; R Di Lenarda; M Piovesana
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-04       Impact factor: 2.503

8.  Morbidity, mortality and cost from HPV-related oropharyngeal cancer: Impact of 2-, 4- and 9-valent vaccines.

Authors:  Greg Ward; Vikas Mehta; Michael Moore
Journal:  Hum Vaccin Immunother       Date:  2015-11-13       Impact factor: 3.452

9.  Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.

Authors:  Neil Gildener-Leapman; Jeehong Kim; Shira Abberbock; Garret W Choby; Rajarsi Mandal; Umamaheswar Duvvuri; Robert L Ferris; Seungwon Kim
Journal:  Head Neck       Date:  2016-05-26       Impact factor: 3.147

10.  Transoral laser resection versus lip-split mandibulotomy in the management of oropharyngeal squamous cell carcinoma (OPSCC): a case match study.

Authors:  C E Williams; A J Kinshuck; S G Derbyshire; N Upile; S Tandon; N J Roland; S R Jackson; J Rodrigues; D J Husband; J L Lancaster; T M Jones
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-04       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.